Patents
Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
08/2004
08/24/2004US6781011 Bone-related and various other diseases
08/24/2004US6780854 Orally active androgens
08/24/2004US6780853 For modulating brain excitability
08/19/2004US20040162425 6,7-Oxygenated steroids and uses related thereto
08/12/2004WO2004067547A2 Novel steroids and steroid mimetics, method for the production and use thereof
08/12/2004US20040157814 6, 7-Oxygenated steroids and uses related thereto
08/10/2004CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes
08/05/2004WO2004064722A2 Process for the production of oxandrolone
08/05/2004US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders
08/05/2004DE10006155B4 Verfahren zur Herstellung von 16α-[18F] Fluorestradiolsulfamaten Process for the preparation of 16α- [18F] Fluorestradiolsulfamaten
08/04/2004EP0988311B1 Betulinol derivatives
08/04/2004EP0740708B1 Design of drugs involving receptor-ligand-dna interactions
07/2004
07/29/2004WO2004062606A2 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
07/29/2004WO2004045560A3 Combination of monounsaturated fatty acids and estogen, and their use
07/29/2004WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men
07/29/2004US20040147496 Novel estrogenic compounds
07/29/2004DE10303671A1 New 8alpha,14beta-dialkyl-18-nor steroids useful as pharmaceuticals, intermediates or carriers for treating e.g. tumors, alzheimers disease
07/29/2004DE10303670A1 New 14beta-alkyl-18-nor steroids useful as pharmaceuticals, e.g. for treating inflammation or tumors, or pharmaceutical intermediates
07/29/2004DE10303667A1 New 14-fluoro-15,17-dihydroxysteroid derivatives, useful for treating Alzheimer's disease and tumors, and as intermediates, are e.g. inhibitors of steroid dehydrogenase
07/28/2004EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them
07/28/2004EP0823895B1 Fatty acid esters as bioactive compounds
07/28/2004CN1159014C Use of 4 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis
07/27/2004US6767903 New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
07/27/2004US6767902 Androgen as a male contraceptive and non-contraceptive androgen replacement
07/22/2004US20040142915 11beta-short chain substituted estradiol analogs and their use in the treatment of menopausal symptoms and estrogen sensitive cancer
07/21/2004CN1158274C Benzopyran-containing compounds and method for their use
07/15/2004WO2004011663A3 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
07/15/2004US20040138486 Steroid with cyclohexene and oxidized unsaturated ketone oxidized with copper iodide and tert-butyl hydroperoxide
07/15/2004US20040138193 Administering by mouth
07/14/2004EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
07/14/2004EP1435967A2 Methods for preventing and treating bone loss with steroid compounds
07/13/2004US6762175 Fatty acid derivatives
07/08/2004WO2004016640A3 5 ANDROSTEN-3β-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
07/08/2004US20040133020 Methods for preparing 7alpha-hydroxy-dehydroepiandrosterone
07/08/2004US20040132698 Androgen as a male contraceptive and non-contraceptive androgen replacement
07/08/2004DE10259004A1 Use of new and known glucocorticoid receptor antagonists for treating hypogonadism, sexual dysfunction and infertility, with minimal effect on progesterone receptor
07/01/2004WO2004041839A3 Synthesis of estetrol via estrone derived steroids
07/01/2004US20040127702 Novel crystal form
07/01/2004US20040126418 7-alpha-methyl-19-nortestosterone (MENT); androgens; improved bioavailability
06/2004
06/29/2004US6756366 Orally active androgens
06/23/2004EP1430073A1 Solvent extraction process
06/23/2004EP1429779A2 Androstanes as androgen receptor modulators
06/17/2004US20040116673 Prodrugs; bone disorders
06/17/2004US20040116359 Administering 16 alpha -bromo-3 beta -hydroxy-5 alpha -androstan-17-one hemihydrate and one or more excipients for therapy of pathogen infection, an autoimmune disease, inflammation or allergy, osteoporosis, acute myelitis, sarcoidosis, a cancer
06/16/2004EP1427748A1 17alpha-hydroxy-14beta-steroids with hormonal effect
06/16/2004EP1058552B1 Steroid derived antibiotics
06/16/2004EP0977725B1 New fatty acid derivatives
06/10/2004WO2004037844A8 Crystalline 17beta-hydroxy-7alpha- (5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone
06/09/2004CN1152847C Method for prepn. of steroid derivative ketal
06/03/2004WO2004045560A2 Combination of monounsaturated fatty acids and estogen, and their use
06/03/2004CA2543393A1 Combination of monounsaturated fatty acids and estrogen, and their use
06/02/2004EP1423125A1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
06/02/2004CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
06/02/2004CN1152045C Method for preparing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and the intermediate products obtained in said method
06/02/2004CN1152044C C21 steriod glycoside extracted from cynanchum bunaei with antineoplastic function
05/2004
05/27/2004WO2004043987A1 Processes for preparing 7-carboxy substituted steroids
05/27/2004WO2004043986A1 Processes for preparing c-7 substituted 5-androstenes
05/27/2004WO2002090375A8 Liver x receptor agonists
05/27/2004US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
05/27/2004US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer
05/27/2004CA2504745A1 Processes for preparing 7-carboxy substituted steroids
05/27/2004CA2500580A1 Processes for preparing c-7 substituted 5-androstenes
05/26/2004EP1422234A2 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
05/26/2004EP1420805A1 Aromatase marking
05/26/2004EP1420769A2 Lipid profile modulation with steroids
05/26/2004EP0740650B1 Codrugs as a method of controlled drug delivery
05/21/2004WO2004041839A2 Synthesis of estetrol via estrone derived steroids
05/21/2004WO2004014934A3 Process and new intermediates for the preparation of steroids with a progestogen activity
05/20/2004US20040097479 For use as drug
05/20/2004US20040097477 For controlling male fertility in a mammal
05/20/2004US20040097475 Reacting steroid intermediate with nucleophilic reagent in presence of Lewis acid catalyst to produce 7-substituted steroid compound
05/20/2004US20040097406 Pharmaceutical compositions and treatment methods - 4
05/19/2004EP1418921A1 Anti-tumour 2-alkoxyestradiol sulfamates
05/19/2004CN1498222A Steroidal derivatives
05/13/2004US20040092492 Reacting a corresponding aldehyde with hydroxylamine compound forming oxime group
05/12/2004EP1416937A1 Prophylactic and therapeutic use of hydroxysteroids
05/06/2004WO2004037844A1 Crystalline 17beta-hydroxy-7alpha- (5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone
05/06/2004WO2004037173A2 Method for treating erectile dysfunction and increasing libido in men
05/06/2004WO2004011663A9 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
05/06/2004WO2003104254A3 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders
05/06/2004WO2002101014B1 A process for making estra-4,9(10)-diene steroids
05/06/2004US20040087785 Process for making estra-4,9(10)-diene steroids
05/06/2004US20040087562 Chemical intermediate; carbonylation using carbon monoxide using palladium catalyst
05/06/2004EP1414465A2 Use of inhibitors of progesterone receptor for treating cancer
05/06/2004EP0775155B1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them
05/06/2004CA2502607A1 Method for treating erectile dysfunction and increasing libido in men
05/04/2004CA2090264C Method of preparing 9beta, 10alpha-5,7-diene steroids
04/2004
04/29/2004WO2004035817A1 Method and reagent for measuring cholesterol in high-density lipoproteins
04/29/2004US20040082556 Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use
04/28/2004EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
04/28/2004CN1491957A Process for preparing anti-cancer medicine Exemestane
04/22/2004WO2003102012A3 New etonogestrel esters
04/22/2004WO2003082895A3 Process to prepare eplerenone
04/20/2004US6723858 Breaking cell dividing, reproduction cycles
04/15/2004WO2003082894A3 C-17 spirolactonization and 6,7 oxidation of steroids
04/15/2004US20040072813 Estrogenic compounds as anti-mitotic agents
04/15/2004US20040072812 Extraction from pregnant horse urine; hormone replacement therapy
04/14/2004EP1406636A2 System and method for the large scale labeling of compounds with radiohalogens
04/14/2004EP1406591A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone
04/13/2004US6720307 Antibiotic; against antibiotic resistant microorganisms
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 49